ERG Clinical Trial Sites Contribute to Approval of Regeneron’s COVID-19 Treatment
With COVID-19 cases rising at alarming rates across the US, Emergency Use Authorization of Regeneron’s COVID treatment couldn’t have come soon enough. The FDA announced late last month that casirivimab and imdevimab, two monoclonal antibodies, were authorized for emergency use in patients with mild and moderate Coronavirus Disease 2019. Clinical trials demonstrated that the two …
